The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Mechanisms of osteolytic bone metastases in breast carcinoma
Open accessAbstract
Osteolytic and osteoblastic metastases are often the cause of considerable morbidity in patients with advanced prostate and breast carcinoma. Breast carcinoma metastasis to bone occurs because bone provides a favorable site for aggressive behavior of metastatic cancer cells. A vicious cycle arises between cancer cells and the bone microenvironment, which is mediated by the production of growth factors such as transforming growth factor beta and insulin growth factor from bone and parathyroid hormone-related protein (PTHrP) produced by tumor cells. Osteolysis and tumor cell accumulation can be interrupted by inhibiting any of these limbs of the vicious cycle. For example, bisphosphonates (e.g., pamidronate, ibandronate, risedronate, clodronate, and zoledronate) inhibit both bone lesions and tumor cell burden in bone in experimental models of breast carcinomametastasis. Neutralizing antibodies to PTHrP, which inhibit PTHrP effects on osteoclastic bone resorption, also reduce osteolytic bone lesions and tumor burden in bone. Other pharmacologic approaches to inhibit PTHrP produced by breast carcinoma cells in the bone microenvironment also produce similar beneficial effects. Identification of the molecular mechanisms responsible for osteolytic metastases is crucial in designing effective therapy for this devastating complication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 1×
“It enhances the differentiation and fusion of active osteoclasts in the presence of macrophage– colony-stimulating factor.(27,28) Concomitantly, the production of a soluble decoy receptor for RANKL, osteoprotegerin, by osteoblastic stromal cells is down-regulated.”
BackgroundMetastatic potential correlates with enzymatic degradation of basement membrane collagen
Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., & Shafie, S. (1980) · Nature · doi:10.1038/284067a0 · Cited by 1,768
Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 986
Self-citationHauschka, P. V., Mavrakos, A. E., Iafrati, M. D., Doleman, S. E., & Klagsbrun, M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67143-1 · Cited by 869
Guise, T. A., Yin, J. J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., & Mundy, G. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118947 · Cited by 851
Self-citationSoluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
Parathyroid hormone-related protein purified from a human lung cancer cell line.
Moseley, J. M., Kubota, M., Diefenbach-Jagger, H., Wettenhall, R. E., Kemp, B. E., Suva, L. J., Rodda, C. P., Ebeling, P. R., Hudson, P. J., & Zajac, J. D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.5048 · Cited by 734
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
Thomas, R. J., Guise, T. A., Yin, J. J., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (1999) · Endocrinology · doi:10.1210/endo.140.10.7037 · Cited by 536
Tumor cell autocrine motility factor.
Liotta, L. A., Mandler, R., Murano, G., Katz, D. A., Gordon, R. K., Chiang, P. K., & Schiffmann, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3302 · Cited by 533
Lee, S.-K., & Lorenzo, J. A. (1999) · Endocrinology · doi:10.1210/endo.140.8.6887 · Cited by 464
Zhang, J., Dai, J., Qi, Y., Lin, D.-L., Smith, P., Strayhorn, C., Mizokami, A., Fu, Z., Westman, J., & Keller, E. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11685 · Cited by 452
Hanafusa, H., Ninomiya-Tsuji, J., Masuyama, N., Nishita, M., Fujisawa, J.-I., Shibuya, H., Matsumoto, K., & Nishida, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27161 · Cited by 442
TGF-β signaling by Smad proteins
Miyazono, K., Ten Dijke, P., & Heldin, C.-H. (2000) · Advances in Immunology · doi:10.1016/s0065-2776(00)75003-6 · Cited by 433
Pfeilschifter, J., & Mundy, G. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2024 · Cited by 431
Self-citationPowell, G. J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1991) · PubMed · Cited by 390
The Cellular Basis of Site-Specific Tumor Metastasis
Flier, J. S., Underhill, L. H., & Zetter, B. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003013220907 · Cited by 349
Role of Ras and Mapks in TGFβ signaling
Mulder, K. M. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00026-x · Cited by 348
Käkönen, S.-M., Selander, K. S., Chirgwin, J. M., Yin, J. J., Burns, S., Rankin, W. A., Grubbs, B. G., Dallas, M., Cui, Y., & Guise, T. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202561200 · Cited by 276
Self-citationWrana, J. L., & Attisano, L. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00024-6 · Cited by 259
de la Mata, J., Uy, H. L., Guise, T. A., Story, B., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117990 · Cited by 255
Self-citationImmunohistochemical localization of parathyroid hormone-related protein in human breast cancer.
Southby, J., Kissin, M. W., Danks, J. A., Hayman, J., Moseley, J. M., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1990) · PubMed · Cited by 249
Yoneda, T., Sasaki, A., Dunstan, C., Williams, P. J., Bauss, F., De Clerck, Y. A., & Mundy, G. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119435 · Cited by 247
Self-citationDirect resorption of bone by human breast cancer cells in vitro
EILON, G., & MUNDY, G. R. (1978) · Nature · doi:10.1038/276726a0 · Cited by 235
Self-citationTransforming growth factor β signaling mediators and modulators
Zimmerman, C. M., & Padgett, R. W. (2000) · Gene · doi:10.1016/s0378-1119(00)00162-1 · Cited by 174
Biochemical markers and skeletal metastases
Demers, L. M., Costa, L., & Lipton, A. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+<2919::aid-cncr7>3.0.co;2-z · Cited by 161
Scanning electron microscopy in bone pathology: review of methods, potential and applications.
BOYDE, A., Maconnachie, E., Reid, S. A., Delling, G., & Mundy, G. R. (1986) · PubMed · Cited by 159
Self-citationCancer Invasion and Metastases
Liotta, L. A. (1990) · JAMA · doi:10.1001/jama.1990.03440080101032 · Cited by 142
van der Pluijm, G., Sijmons, B., Vloedgraven, H. J., Deckers, M. M. L., Papapoulos, S. E., & Löwik, C. W. G. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1077 · Cited by 124
Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production
Elias, J. A., Tang, W., & Horowitz, M. C. (1995) · Endocrinology · doi:10.1210/endo.136.2.7835281 · Cited by 114
Chikatsu, N., Takeuchi, Y., Tamura, Y., Fukumoto, S., Yano, K., Tsuda, E., Ogata, E., & Fujita, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.2008 · Cited by 95 · cited 2×
“Interleukin (IL)-11, an IL-6 family cytokine, is produced by a variety of stromal cells including fibroblasts, epithelial cells, and osteoblasts and has pleiotropic effects on a variety of tissues.30 It enhances bone resorption by promoting osteoclastogenesis31 and suppressing the activity of osteoblasts.32 In additio…”
BackgroundKiriyama, T., Gillespie, M. T., Glatz, J. A., Fukumoto, S., Moseley, J. M., & Martin, T. J. (1993) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(93)90074-t · Cited by 89
Bone destruction and hypercalcemia in plasma cell myeloma.
Mundy, G. R., & Bertolini, D. R. (1986) · PubMed · Cited by 88
Self-citationInterleukin-11 inhibits bone formation in vitro
Hughes, F. J., & Howells, G. L. (1993) · Calcified Tissue International · doi:10.1007/bf01351844 · Cited by 80
Lee, J., Weber, M. H., Mejia, S., Bone, E. A., Watson, P. H., & Orr, W. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00363-4 · Cited by 60
Zhang, Y., Fujita, N., Oh‐hara, T., Morinaga, Y., Nakagawa, T., Yamada, M., & Tsuruo, T. (1998) · Oncogene · doi:10.1038/sj.onc.1201581 · Cited by 56
Uy, H. L., Mundy, G. R., Boyce, B. F., Story, B. M., Dunstan, C. R., Yin, J. J., Roodman, G. D., & Guise, T. A. (1997) · PubMed · Cited by 55
Self-citationProduction and regulation of interleukin-11 by breast cancer cells
Lacroix, M., Siwek, B., Marie, P. J., & Body, J. J. (1998) · Cancer Letters · doi:10.1016/s0304-3835(97)00542-9 · Cited by 52
Morinaga, Y., Fujita, N., Ohishi, K., & Tsuruo, T. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<422::aid-ijc20>3.0.co;2-g · Cited by 50
Interleukin‐11: Its Biology and Prospects for Clinical Use
Grosfeld, J. L., Du, X., & Williams, D. A. (1999) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719902300517 · Cited by 25
Käkönen, S.-M., Selander, K. S., Carreon, M. R., Cui, Y., Neal, M. E. H., Chirgwin, J. M., Grubbs, B. G., & Guise, T. A. (2001) · Breast Cancer Research and Treatment · Cited by 2
Self-citation
Cited by
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
A timeline of tumour-associated macrophage biology
Cassetta, L., & Pollard, J. W. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00547-1 · Cited by 581
Role of the Tumor Microenvironment in Breast Cancer
Soysal, S. D., Tzankov, A., & Muenst, S. E. (2015) · Pathobiology · doi:10.1159/000430499 · Cited by 510
Advances in the regulation of osteoclasts and osteoclast functions
Boyce, B. F. (2013) · Journal of Dental Research · doi:10.1177/0022034513500306 · Cited by 457
Molecular Biology of Bone Metastasis
Kingsley, L. A., Fournier, P. G. J., Chirgwin, J. M., & Guise, T. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0234 · Cited by 435
Metadata
- Authors
- K�k�nen, S.-M., & Mundy, G. R.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-01-23
- Volume
- 97
- Issue
- S3
- Pages
- 834-839
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2111807012
- Cited by
- 269
- References
- 41
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.